How much funding has SciThera raised?

SciThera has raised $26.0M in total funding, most recently a Seed round.

Who are SciThera's investors?

SciThera's investors include Venrock.

Where is SciThera headquartered?

SciThera is headquartered in San Diego, California, United States.

SciThera

San Diego, United States · $26.0M raised

Biotech

Headquarters: San Diego, California
Business Model: B2B
Website: scithera.bio

Total Funding: $26.0M
Last Round: $26.0M SeedJan 2025
Rounds: 1

About

SciThera, Inc. is a San Diego, California-based biotechnology company focused on discovering and developing novel antibody-based therapeutics, including antibody-drug conjugates, for the treatment of cancer. According to an SEC filing by Inhibrx, SciThera is a newly formed biotechnology company that focuses on antibody-based molecules and has entered into a licensing agreement with Inhibrx. SciThera is backed by venture capital firm Venrock and led by CEO Brendan Eckelman.

Summary

SciThera is a Biotech company based in San Diego, United States. It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in Jan 2025. Investors include Venrock.